The Neuro Experience: Maintain a Healthy Heart and Prevent Heart Disease | Featuring Dr. Prakriti Gaba
Date: July 12, 2023
Host: Louisa Nicola
Guest: Dr. Prakriti (PK) Gaba, Cardiology Fellow at Brigham and Women’s Hospital, Harvard Medical School
Overview
In this episode, host Louisa Nicola welcomes Dr. Prakriti Gaba to demystify cardiovascular disease and provide a deep dive into cholesterol, arterial health, genetic risk, lifestyle interventions, and innovative prevention strategies. The conversation targets common myths, clarifies cutting-edge science, and offers practical insights for listeners aiming to understand and proactively manage heart health.
Key Discussion Points & Insights
1. What is Cardiovascular Disease?
[04:24–05:21]
- CVD includes any problem affecting blood vessels: heart attacks (coronary arteries), strokes (brain arteries), kidney disease, and peripheral vascular disease.
- Blockages can occur in both arteries and veins, but arterial blockages generally carry higher risks and severe consequences.
"Cardiovascular disease is sort of this big bucket term for problems that can happen in the blood vessels of the heart and vasculature of the body and then create bad things." — Dr. Gaba [04:24]
2. Arteries vs. Veins and Blockages
[05:53–08:21]
- Arterial disease is primarily about slowly progressing plaque buildup, causing narrowed vessels, occlusion, and potentially catastrophic events like heart attacks.
- Venous disease, such as deep vein thrombosis (DVT), is also dangerous, especially if a clot travels to the lungs (pulmonary embolism).
3. Plaque Formation, Heart Attack Severity
[08:47–11:38]
- Plaque rupture in the arteries, triggered by stress or physical events, can cause clot formation and vessel occlusion, leading to heart attacks.
- Minor vs. major heart attacks depend on which artery is blocked and how much heart muscle (myocardium) the vessel supplies.
"If you have a narrowing in that left main and then you have some stressful trigger ... then you're essentially blocking more than 2/3 of blood going to the heart. ... That is sort of the most severe type of heart attack one can have." — Dr. Gaba [10:24]
4. Cholesterol: Good vs. Bad and How It’s Measured
[13:43–17:40]
- Cholesterol is a waxy substance needed for cell function, but excess—especially LDL ("bad" cholesterol)—raises heart risk.
- Lipid panels measure total cholesterol, LDL (bad), HDL (good), and triglycerides. Elevated LDL is specifically linked to plaque formation.
"Managing cholesterol is one of the best things we can do to help our cardiovascular health." — Dr. Gaba [13:43]
5. Understanding Triglycerides and Lipoproteins
[15:41–18:05]
- Triglycerides are separate from cholesterol but also elevate heart risk.
- LDL is the main cholesterol fraction implicated in arterial plaque.
6. APOB, APOA, and Lipoprotein(a) – The Next Frontier
[18:05–25:45]
- APOB is a key protein component in LDL; high APOB is even more strongly associated with cardiac events than LDL alone.
- Measuring APOB gives a better risk profile, though not always part of standard screenings.
- Lipoprotein(a) consists of an LDL-like particle attached to APOA; it's mostly genetically determined and less influenced by diet/exercise.
- Elevated Lipoprotein(a) is linked to unexpected cardiac events—even in seemingly healthy, athletic individuals.
"APOB ... is associated with those bad things like MI—heart attacks, death, strokes, even more so than, you know, triglycerides or the LDL itself." — Dr. Gaba [18:36]
"Lipoprotein A ... is primarily genetically mediated. ... Diet and exercise tend to not affect its levels substantially." — Dr. Gaba [23:02]
7. Inflammation and Heart Disease
[26:42–32:53]
- Heart disease is driven by two main factors: cholesterol and inflammation.
- Markers like CRP and IL-6 are important but not routinely checked; new medications targeting inflammation could transform future treatment.
"Heart disease ... is (from) high cholesterol and also inflammation. ... We're still not great at addressing (inflammation) and the mechanism is not fully understood." — Dr. Gaba [27:24]
8. Dietary Impact on Cholesterol
[33:28–35:31]
- Diet directly influences cholesterol levels. Saturated fats increase LDL ("bad") cholesterol; fiber and omega-3s are beneficial.
- "Good fats," like those in avocados and fish, can be anti-inflammatory.
"100% what you eat will affect your cholesterol levels ... eating foods that are high in cholesterol will increase your overall body cholesterol." — Dr. Gaba [33:28]
9. Role of Exercise in Heart Health
[35:41–38:30]
- Exercise stabilizes plaques and reduces inflammation, lowering risk even if it doesn’t “clean” blocked arteries.
- Both diet and exercise are vital: diet reduces risk and new plaque, while exercise stabilizes existing plaque.
10. Fiber & Other Diet Approaches
[38:30–40:24]
- High-fiber diets reduce risk mainly by promoting satiety, reducing unhealthy food consumption, and lowering diabetes risk.
11. Cholesterol Targets: What is ‘High Risk’?
[41:26–42:20]
- LDL targets have gotten stricter; <100 mg/dL (and ideally <90) is now considered optimal.
- APOB targets are generally set the same as LDL.
"For people like you and I, your LDL cholesterol should really be 100 milligrams per deciliter or less. If you're higher than that, you have a substantially higher risk of developing heart disease." — Dr. Gaba [41:26]
12. Genetics & Tests: Statins, PCSK9 Inhibitors, and Precision Medicine
[44:13–47:45]
- Genetics affect LDL levels (e.g., variations in HMG-CoA reductase and PCSK9 genes).
- PCSK9 inhibitors and statins were designed based on these genetic discoveries; future genetic profiling could inform truly personalized prevention.
13. Statins: Benefits, Risks, and Myths
[47:55–55:21]
- Statins lower LDL by inhibiting HMG-CoA reductase, preventing further plaque buildup, possibly stabilizing or regressing existing plaque due to anti-inflammatory effects.
- Side effects (e.g., muscle myopathy) are rare; benefits in preventing heart attacks and strokes far outweigh risks.
- For high-risk individuals, guidelines push even lower LDL cutoffs (Europe: ≤55 mg/dL).
"Statins ... decrease the amounts of circulating bad cholesterol ... to prevent more plaque buildup in the arteries of the heart and the arteries of the brain." — Dr. Gaba [48:03]
14. Supplements: Are Alternatives Effective?
[55:21–57:32]
- Many supplements (berberine, red yeast rice) are popular but generally less effective or even risky compared to statins for cholesterol reduction.
"Some of the supplements actually increased your risk of having the adverse event. ... Definitely the statin reduced your LDL the most and also decreased your risk the most." — Dr. Gaba [56:13]
15. Smoking & Other Non-Diet Risks
[57:50–59:29]
- Smoking accelerates inflammation and arterial disease of the heart and other organs, dramatically increasing acute heart attack and stroke risk.
"Smoking ... increases the level of inflammation in the body. ... That plaque that's unstable ... just ruptures, and they have a heart attack right away." — Dr. Gaba [58:08]
16. Screening and Precision Prevention
[62:04–64:34]
- Tools like the Coronary Artery Calcium (CAC) score are powerful for identifying hidden risk and starting early, targeted interventions.
"A coronary artery calcium score will let you see ... what the amount of calcium is in their body or in their heart or the vessels of the heart. ... If it's not zero, they should strongly consider being on a statin." — Dr. Gaba [62:25]
17. Atrial Fibrillation & Risk Management
[64:34–70:20]
- AFib may be “silent,” carries risk for stroke and (rarely) heart attacks due to blood pooling and clotting. Wearable technology and improved screening methods are improving detection.
- Sleep apnea is a significant, modifiable risk factor for AFib.
Memorable Quotes & Moments
-
On the unknowns of heart disease:
“So we can go to Mars ... but we can't understand LP exactly.” — Louisa Nicola [22:54]
-
On statin skepticism:
“There is ... this hesitation by some to take the medication. ... But the actual incidence [of myopathy] is very, very low. So less than 10% or even less than 5% ...” — Dr. Gaba [52:31]
-
On health education:
“I always believe education is probably at the first point of prevention.” — Louisa Nicola [13:02]
Timestamps: Quick Reference for Major Segments
- Cardiovascular Disease Defined: [04:24]
- Arteries vs. Veins, Plaque: [05:53–08:21]
- What Differentiates Minor vs. Major Heart Attacks: [09:52–11:38]
- Cholesterol and Lipid Panel Explained: [13:43–17:40]
- APOB, APOA, Lipoprotein(a) Genetic Risks: [18:05–25:45]
- Inflammation’s Role in CVD: [26:42–32:53]
- Diet and Cholesterol: [33:28–35:31]
- Exercise and Plaque Stability: [35:41–38:30]
- Cholesterol Cutoffs and Risk: [41:26–42:20]
- Genetic Testing and Personalized Medicine: [44:13–47:45]
- Statins vs. Supplements for Risk Reduction: [47:55–55:21]
- Smoking, Lifestyle, and Heart Health: [57:50–59:29]
- Coronary Calcium Screening: [62:04–64:34]
- Atrial Fibrillation & Wearables: [64:34–70:20]
Tone & Delivery
The conversation balances scientific rigor with practical advice, combining Louisa’s candid, curious style and Dr. Gaba’s expertise and clarity. They repeatedly reference real-life scenarios, patient challenges, and emerging scientific research, using analogies (“plaque like pipes”) to demystify complex topics.
Final Takeaways
- Heart disease arises from both lipid (cholesterol) and inflammatory pathways—prevention should address both.
- LDL and APOB are key actionable markers, but Lipoprotein(a) signals hidden, often genetic risk.
- Diet and exercise are foundational; statins remain the most evidence-based pharmacological intervention.
- New tools (genetic testing, calcium scoring, wearables) are ushering in a new era of personalized cardiac prevention.
Guest Info:
Dr. Prakriti Gaba is active on Twitter @prakritigaba
Host:
Louisa Nicola @louisanicola_
For the full episode and more neurologically-informed performance insights, subscribe to The Neuro Experience.